Zydus Lifesciences Limited (ZYDUSLIFE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zydus Lifesciences Limited (ZYDUSLIFE) has a cash flow conversion efficiency ratio of 0.018x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.68 Billion ≈ $39.84 Million USD) by net assets (Rs209.41 Billion ≈ $2.26 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zydus Lifesciences Limited - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Zydus Lifesciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Zydus Lifesciences Limited carry for a breakdown of total debt and financial obligations.
Zydus Lifesciences Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zydus Lifesciences Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
OGE Energy Corporation
NYSE:OGE
|
0.077x |
|
RYOHIN UNSP.ADR/1
F:3RKU
|
N/A |
|
Getlink SE
PA:GET
|
0.135x |
|
Shenzhen Transsion Holdings Co Ltd
SHG:688036
|
0.165x |
|
Waaree Energies Limited
NSE:WAAREEENER
|
0.088x |
|
Macrotech Developers Limited
NSE:LODHA
|
0.062x |
|
Viper Energy Ut
NASDAQ:VNOM
|
0.039x |
|
Revvity Inc.
NYSE:RVTY
|
0.025x |
Annual Cash Flow Conversion Efficiency for Zydus Lifesciences Limited (2004–2025)
The table below shows the annual cash flow conversion efficiency of Zydus Lifesciences Limited from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see ZYDUSLIFE market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs263.58 Billion ≈ $2.85 Billion |
Rs67.77 Billion ≈ $732.87 Million |
0.257x | +77.78% |
| 2024-03-31 | Rs221.02 Billion ≈ $2.39 Billion |
Rs31.96 Billion ≈ $345.67 Million |
0.145x | +5.89% |
| 2023-03-31 | Rs196.88 Billion ≈ $2.13 Billion |
Rs26.89 Billion ≈ $290.78 Million |
0.137x | +23.67% |
| 2022-03-31 | Rs190.54 Billion ≈ $2.06 Billion |
Rs21.04 Billion ≈ $227.55 Million |
0.110x | -49.93% |
| 2021-03-31 | Rs149.30 Billion ≈ $1.61 Billion |
Rs32.93 Billion ≈ $356.13 Million |
0.221x | +3.10% |
| 2020-03-31 | Rs117.10 Billion ≈ $1.27 Billion |
Rs25.05 Billion ≈ $270.95 Million |
0.214x | -13.31% |
| 2019-03-31 | Rs116.79 Billion ≈ $1.26 Billion |
Rs28.82 Billion ≈ $311.71 Million |
0.247x | +139.88% |
| 2018-03-31 | Rs89.36 Billion ≈ $966.34 Million |
Rs9.19 Billion ≈ $99.42 Million |
0.103x | -45.75% |
| 2017-03-31 | Rs71.16 Billion ≈ $769.58 Million |
Rs13.49 Billion ≈ $145.94 Million |
0.190x | -47.81% |
| 2016-03-31 | Rs54.87 Billion ≈ $593.43 Million |
Rs19.94 Billion ≈ $215.62 Million |
0.363x | +61.65% |
| 2015-03-31 | Rs44.20 Billion ≈ $478.06 Million |
Rs9.94 Billion ≈ $107.45 Million |
0.225x | -9.20% |
| 2014-03-31 | Rs35.83 Billion ≈ $387.52 Million |
Rs8.87 Billion ≈ $95.93 Million |
0.248x | +28.35% |
| 2013-03-31 | Rs30.64 Billion ≈ $331.34 Million |
Rs5.91 Billion ≈ $63.90 Million |
0.193x | +2.37% |
| 2012-03-31 | Rs26.64 Billion ≈ $288.10 Million |
Rs5.02 Billion ≈ $54.28 Million |
0.188x | -37.02% |
| 2011-03-31 | Rs22.38 Billion ≈ $242.07 Million |
Rs6.70 Billion ≈ $72.41 Million |
0.299x | -21.11% |
| 2010-03-31 | Rs16.68 Billion ≈ $180.36 Million |
Rs6.32 Billion ≈ $68.39 Million |
0.379x | +118.22% |
| 2009-03-31 | Rs12.58 Billion ≈ $136.05 Million |
Rs2.19 Billion ≈ $23.64 Million |
0.174x | +1.43% |
| 2008-03-31 | Rs10.82 Billion ≈ $116.97 Million |
Rs1.85 Billion ≈ $20.04 Million |
0.171x | -40.22% |
| 2007-03-31 | Rs8.80 Billion ≈ $95.14 Million |
Rs2.52 Billion ≈ $27.26 Million |
0.287x | +80.46% |
| 2006-03-31 | Rs7.00 Billion ≈ $75.66 Million |
Rs1.11 Billion ≈ $12.02 Million |
0.159x | -58.87% |
| 2005-03-31 | Rs5.93 Billion ≈ $64.17 Million |
Rs2.29 Billion ≈ $24.78 Million |
0.386x | -11.46% |
| 2004-03-31 | Rs5.36 Billion ≈ $58.01 Million |
Rs2.34 Billion ≈ $25.30 Million |
0.436x | -- |
About Zydus Lifesciences Limited
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Consumer Products. It offers active pharmaceutical ingredients, finished dosage formulations, generics, specialty, biosimilars, vaccines, novel products, con… Read more